News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Jafri Hasan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 options
@ $0.16, valued at
$4k
Exercised 10,000 restricted stock units
@ $0 |
|
| 12/07/2022 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 10/05/2021 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 30,000 options
@ $3.6, valued at
$108k
|
|
| 09/08/2021 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Bought 3,009 shares
@ $4.15, valued at
$12.5k
Bought 1,991 shares
@ $4.15, valued at
$8.3k
Bought 100 shares
@ $3.97, valued at
$397 |
|
| 06/25/2020 |
4/A
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Granted 80,000 options
@ $6.16, valued at
$492.8k
|
|
| 06/25/2020 |
4
| Jafri Hasan (Chief Medical Officer) has filed a Form 4 on Aridis Pharmaceuticals, Inc.|
Txns:
| Exercised 80,000 options
@ $6.16, valued at
$492.8k
|
|
| 06/17/2020 |
3
| Jafri Hasan (Chief Medical Officer) has filed a Form 3 on Aridis Pharmaceuticals, Inc. |
|
|